Correlation Between Vertex Pharmaceuticals and Viridian Therapeutics
Can any of the company-specific risk be diversified away by investing in both Vertex Pharmaceuticals and Viridian Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vertex Pharmaceuticals and Viridian Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vertex Pharmaceuticals and Viridian Therapeutics, you can compare the effects of market volatilities on Vertex Pharmaceuticals and Viridian Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vertex Pharmaceuticals with a short position of Viridian Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vertex Pharmaceuticals and Viridian Therapeutics.
Diversification Opportunities for Vertex Pharmaceuticals and Viridian Therapeutics
0.15 | Correlation Coefficient |
Average diversification
The 3 months correlation between Vertex and Viridian is 0.15. Overlapping area represents the amount of risk that can be diversified away by holding Vertex Pharmaceuticals and Viridian Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Viridian Therapeutics and Vertex Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vertex Pharmaceuticals are associated (or correlated) with Viridian Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Viridian Therapeutics has no effect on the direction of Vertex Pharmaceuticals i.e., Vertex Pharmaceuticals and Viridian Therapeutics go up and down completely randomly.
Pair Corralation between Vertex Pharmaceuticals and Viridian Therapeutics
Given the investment horizon of 90 days Vertex Pharmaceuticals is expected to generate 0.37 times more return on investment than Viridian Therapeutics. However, Vertex Pharmaceuticals is 2.7 times less risky than Viridian Therapeutics. It trades about 0.06 of its potential returns per unit of risk. Viridian Therapeutics is currently generating about 0.0 per unit of risk. If you would invest 31,209 in Vertex Pharmaceuticals on September 4, 2024 and sell it today you would earn a total of 14,488 from holding Vertex Pharmaceuticals or generate 46.42% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Vertex Pharmaceuticals vs. Viridian Therapeutics
Performance |
| Timeline |
| Vertex Pharmaceuticals |
| Viridian Therapeutics |
Vertex Pharmaceuticals and Viridian Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Vertex Pharmaceuticals and Viridian Therapeutics
The main advantage of trading using opposite Vertex Pharmaceuticals and Viridian Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vertex Pharmaceuticals position performs unexpectedly, Viridian Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Viridian Therapeutics will offset losses from the drop in Viridian Therapeutics' long position.| Vertex Pharmaceuticals vs. Candel Therapeutics | Vertex Pharmaceuticals vs. Cingulate Warrants | Vertex Pharmaceuticals vs. Unicycive Therapeutics | Vertex Pharmaceuticals vs. Cardio Diagnostics Holdings |
| Viridian Therapeutics vs. Candel Therapeutics | Viridian Therapeutics vs. Cingulate Warrants | Viridian Therapeutics vs. Unicycive Therapeutics | Viridian Therapeutics vs. Cardio Diagnostics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |